<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543711</url>
  </required_header>
  <id_info>
    <org_study_id>2007-41-1530</org_study_id>
    <nct_id>NCT01543711</nct_id>
  </id_info>
  <brief_title>Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment</brief_title>
  <official_title>Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently
      occurring late effects of breast cancer treatment. The investigators have previously
      published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006.
      Very few studies have examined how these late effects change in time. The aim of this study
      is to examine in a well defined patient population any change in the prevalence of persistent
      pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor
      profile.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of persistent pain</measure>
    <time_frame>6-7 years post operative</time_frame>
    <description>Prevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of patients changing pain status from the 2008 survey</measure>
    <time_frame>6-7 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of sensory disturbance</measure>
    <time_frame>6-7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of self reported lymphedma</measure>
    <time_frame>6-7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of functional impairment</measure>
    <time_frame>6-7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment</measure>
    <time_frame>6-7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of patients changing status of sensory disturbances and self reported lymphedma</measure>
    <time_frame>6-7 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors associated to changing status of sensory disturbances and lymphedema</measure>
    <time_frame>6-7 years post operative</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2411</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Pain</condition>
  <condition>Post Operative Pain</condition>
  <condition>Lymphedema</condition>
  <condition>Neuropathy</condition>
  <arm_group>
    <arm_group_label>Breast cancer survivors</arm_group_label>
    <description>Women treated for breast cancer, without signs of recurrence or metastasis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Woman treated for breast cancer in Denmark 2005-2006, and participated in the study in 2008
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with primary breast cancer between 2005-2006

          -  Participated in a study in 2008

        Exclusion Criteria:

          -  Recurrent or new primary cancer

          -  Metastatic cancer

          -  Reconstructive surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Geving Andersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet, Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>GÃ¤rtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009 Nov 11;302(18):1985-92. doi: 10.1001/jama.2009.1568. Erratum in: JAMA. 2012 Nov 21;308(19):1973.</citation>
    <PMID>19903919</PMID>
  </reference>
  <reference>
    <citation>Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. doi: 10.1016/j.jpain.2010.12.005. Epub 2011 Mar 24. Review.</citation>
    <PMID>21435953</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2012</study_first_submitted>
  <study_first_submitted_qc>March 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2012</study_first_posted>
  <last_update_submitted>June 5, 2013</last_update_submitted>
  <last_update_submitted_qc>June 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Kenneth Geving Andersen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>persistent pain</keyword>
  <keyword>neuropathic pain</keyword>
  <keyword>lymphedema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

